BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 15659052)

  • 1. Granulocyte colony stimulating factor/macrophage colony stimulating factor improves postinfarct ventricular function by suppression of border zone remodelling in rats.
    Miki T; Miura T; Nishino Y; Yano T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ura N; Shimamoto K
    Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):873-82. PubMed ID: 15659052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair.
    Yano T; Miura T; Whittaker P; Miki T; Sakamoto J; Nakamura Y; Ichikawa Y; Ikeda Y; Kobayashi H; Ohori K; Shimamoto K
    J Am Coll Cardiol; 2006 Feb; 47(3):626-34. PubMed ID: 16458148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction.
    Sugano Y; Anzai T; Yoshikawa T; Maekawa Y; Kohno T; Mahara K; Naito K; Ogawa S
    Cardiovasc Res; 2005 Feb; 65(2):446-56. PubMed ID: 15639484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction.
    Maekawa Y; Anzai T; Yoshikawa T; Sugano Y; Mahara K; Kohno T; Takahashi T; Ogawa S
    J Am Coll Cardiol; 2004 Oct; 44(7):1510-20. PubMed ID: 15464336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor and stem cell factor improve endogenous repair after myocardial infarction.
    Kanellakis P; Slater NJ; Du XJ; Bobik A; Curtis DJ
    Cardiovasc Res; 2006 Apr; 70(1):117-25. PubMed ID: 16497284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats.
    Li Y; Fukuda N; Yokoyama S; Kusumi Y; Hagikura K; Kawano T; Takayama T; Matsumoto T; Satomi A; Honye J; Mugishima H; Mitsumata M; Saito S
    Eur J Pharmacol; 2006 Nov; 549(1-3):98-106. PubMed ID: 16979158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of combined therapy of granulocyte colony stimulating factor and bone marrow mesenchymal stem cells carrying hepatocyte growth factor gene on angiogenesis of myocardial infarction in rats].
    Guo Y; Liu C; He J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2011 Jun; 25(6):736-40. PubMed ID: 21735790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
    Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody to granulocyte macrophage colony-stimulating factor reduces the number of activated tissue macrophages and improves left ventricular function after myocardial infarction in a rat coronary artery ligation model.
    Kellar RS; Lancaster JJ; Thai HM; Juneman E; Johnson NM; Byrne HG; Stansifer M; Arsanjani R; Baer M; Bebbington C; Flashner M; Yarranton G; Goldman S
    J Cardiovasc Pharmacol; 2011 May; 57(5):568-74. PubMed ID: 21326109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Woo YJ; Grand TJ; Berry MF; Atluri P; Moise MA; Hsu VM; Cohen J; Fisher O; Burdick J; Taylor M; Zentko S; Liao G; Smith M; Kolakowski S; Jayasankar V; Gardner TJ; Sweeney HL
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):321-9. PubMed ID: 16077394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-colony stimulating factor administration after myocardial infarction in a porcine ischemia-reperfusion model: functional and pathological effects of dose timing.
    Beohar N; Flaherty JD; Davidson CJ; Vidovich M; Singhal S; Rapp JA; Erdogan A; Lee DC; Rammohan C; Brodsky A; Wu E; Pieper K; Virmani R; Bonow RO; Mehta J
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):257-66. PubMed ID: 17253607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of erythropoietin combined with granulocyte-colony stimulating factor in the treatment of acute myocardial infarction in rats].
    Fu ZH; Dong W; Gai LY; Wang F; Ding R; Chen YD
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):17-22. PubMed ID: 21269949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
    Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cells.
    Brunner S; Huber BC; Fischer R; Groebner M; Hacker M; David R; Zaruba MM; Vallaster M; Rischpler C; Wilke A; Gerbitz A; Franz WM
    Exp Hematol; 2008 Jun; 36(6):695-702. PubMed ID: 18346841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-CSF after myocardial infarction accelerates angiogenesis and reduces fibrosis in swine.
    Sato T; Suzuki H; Kusuyama T; Omori Y; Soda T; Tsunoda F; Shoji M; Iso Y; Koba S; Geshi E; Katagiri T; Kawachi K; Wakabayashi K; Takeyama Y
    Int J Cardiol; 2008 Jul; 127(2):166-73. PubMed ID: 17692407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of GM-CSF on the stem cells mobilization and plasma C-reactive protein levels in patients with acute myocardial infarction.
    Deng Z; Yang C; Deng H; Yang A; Geng T; Chen X; Ma A; Liu Z
    Int J Cardiol; 2006 Oct; 113(1):92-6. PubMed ID: 16891014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
    Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
    Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor reduces mortality by suppressing ventricular arrhythmias in acute phase of myocardial infarction in rats.
    Baldo MP; Davel AP; Nicoletti-Carvalho JE; Bordin S; Rossoni LV; Mill JG
    J Cardiovasc Pharmacol; 2008 Oct; 52(4):375-80. PubMed ID: 18841071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F; Thomas W; Way K; Tzanidis A; Kompa A; Lewis D; Itescu S; Krum H
    J Am Coll Cardiol; 2004 Oct; 44(8):1679-89. PubMed ID: 15489104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceleration of the healing process and myocardial regeneration may be important as a mechanism of improvement of cardiac function and remodeling by postinfarction granulocyte colony-stimulating factor treatment.
    Minatoguchi S; Takemura G; Chen XH; Wang N; Uno Y; Koda M; Arai M; Misao Y; Lu C; Suzuki K; Goto K; Komada A; Takahashi T; Kosai K; Fujiwara T; Fujiwara H
    Circulation; 2004 Jun; 109(21):2572-80. PubMed ID: 15123535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.